NO20075153L - Terapeutisk anvendelse av nefopam og analoger derav - Google Patents
Terapeutisk anvendelse av nefopam og analoger deravInfo
- Publication number
- NO20075153L NO20075153L NO20075153A NO20075153A NO20075153L NO 20075153 L NO20075153 L NO 20075153L NO 20075153 A NO20075153 A NO 20075153A NO 20075153 A NO20075153 A NO 20075153A NO 20075153 L NO20075153 L NO 20075153L
- Authority
- NO
- Norway
- Prior art keywords
- nefopam
- analogs
- therapeutic use
- fibromyalgia
- fatigue
- Prior art date
Links
- RGPDEAGGEXEMMM-UHFFFAOYSA-N Nefopam Chemical compound C12=CC=CC=C2CN(C)CCOC1C1=CC=CC=C1 RGPDEAGGEXEMMM-UHFFFAOYSA-N 0.000 title abstract 2
- 229960000751 nefopam Drugs 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title 1
- 208000000094 Chronic Pain Diseases 0.000 abstract 1
- 208000001640 Fibromyalgia Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 206010016256 fatigue Diseases 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/5545—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having eight-membered rings not containing additional condensed or non-condensed nitrogen-containing 3-7 membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0506835.8A GB0506835D0 (en) | 2005-04-04 | 2005-04-04 | Therapeutic use of nefopam |
| PCT/GB2006/001197 WO2006106308A1 (fr) | 2005-04-04 | 2006-03-31 | Utilisation therapeutique du nefopam et analogues de celui-ci |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20075153L true NO20075153L (no) | 2007-10-30 |
Family
ID=34586684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20075153A NO20075153L (no) | 2005-04-04 | 2007-10-10 | Terapeutisk anvendelse av nefopam og analoger derav |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20080255079A1 (fr) |
| EP (1) | EP1868597A1 (fr) |
| JP (1) | JP2008534663A (fr) |
| KR (1) | KR20070121032A (fr) |
| CN (1) | CN101171004A (fr) |
| AU (1) | AU2006231117A1 (fr) |
| BR (1) | BRPI0610663A2 (fr) |
| CA (1) | CA2604396A1 (fr) |
| GB (1) | GB0506835D0 (fr) |
| IL (1) | IL186426A0 (fr) |
| MX (1) | MX2007012300A (fr) |
| NO (1) | NO20075153L (fr) |
| WO (1) | WO2006106308A1 (fr) |
| ZA (1) | ZA200708641B (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2594900T3 (es) * | 2009-12-15 | 2016-12-23 | The Hospital For Sick Children | Método para tratar cicatrices y trastornos mediados por beta-catenina |
| RU2646495C2 (ru) * | 2015-12-28 | 2018-03-05 | Общество с ограниченной ответственностью "Научно-техническая производственная фирма "Анта-Медикал" | Фармацевтические композиции в форме ректальных суппозиториев, содержащие нефопама гидрохлорид (варианты), их применение для лечения острого и хронического болевого синдрома и способы получения |
| US10736905B1 (en) | 2016-09-09 | 2020-08-11 | Shahin Fatholahi | Nefopam dosage forms and methods of treatment |
| US11446311B2 (en) | 2017-09-08 | 2022-09-20 | Shahin Fatholahi | Methods for treating pain associated with sickle cell disease |
| US10736874B1 (en) | 2017-09-08 | 2020-08-11 | Shahin Fatholahi | Methods for treating pain associated with sickle cell disease |
| RU2661618C1 (ru) * | 2017-11-23 | 2018-07-17 | Общество с ограниченной ответственностью "Научно-техническая производственная фирма "Анта-Медикал" | Суппозитории нефопама для лечения острого и хронического болевого синдрома на липофильной основе и способ их получения |
| RU2661617C1 (ru) * | 2017-11-23 | 2018-07-17 | Общество с ограниченной ответственностью "Научно-техническая производственная фирма "Анта-Медикал" | Суппозитории нефопама для лечения острого и хронического болевого синдрома на гидрофильной эмульсионной основе и способ их получения |
| RU2723960C1 (ru) * | 2019-11-12 | 2020-06-18 | Геннадий Владимирович Несповитый | Суппозитории для лечения болевого синдрома средней и высокой интенсивности |
| RU2723952C1 (ru) * | 2019-11-12 | 2020-06-18 | Геннадий Владимирович Несповитый | Суппозитории для лечения болевого синдрома средней и высокой интенсивности |
| RU2723958C1 (ru) * | 2019-11-12 | 2020-06-18 | Геннадий Владимирович Несповитый | Суппозитории для лечения болевого синдрома средней и высокой интенсивности |
| RU2723954C1 (ru) * | 2019-11-12 | 2020-06-18 | Геннадий Владимирович Несповитый | Суппозитории для лечения болевого синдрома средней и высокой интенсивности |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004056788A1 (fr) * | 2002-12-20 | 2004-07-08 | Arakis Ltd. | Benzoxazocines et utilisation de ceux-ci comme inhibiteurs de la recapture des mono-amines |
| AU2005235786A1 (en) * | 2004-04-21 | 2005-11-03 | Sosei R&D Ltd. | Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors |
-
2005
- 2005-04-04 GB GBGB0506835.8A patent/GB0506835D0/en not_active Ceased
-
2006
- 2006-03-31 BR BRPI0610663-3A patent/BRPI0610663A2/pt not_active IP Right Cessation
- 2006-03-31 CN CNA2006800153975A patent/CN101171004A/zh active Pending
- 2006-03-31 EP EP06726603A patent/EP1868597A1/fr not_active Withdrawn
- 2006-03-31 WO PCT/GB2006/001197 patent/WO2006106308A1/fr not_active Ceased
- 2006-03-31 US US11/910,549 patent/US20080255079A1/en not_active Abandoned
- 2006-03-31 CA CA002604396A patent/CA2604396A1/fr not_active Abandoned
- 2006-03-31 AU AU2006231117A patent/AU2006231117A1/en not_active Abandoned
- 2006-03-31 JP JP2008504836A patent/JP2008534663A/ja not_active Withdrawn
- 2006-03-31 MX MX2007012300A patent/MX2007012300A/es unknown
- 2006-03-31 KR KR1020077025161A patent/KR20070121032A/ko not_active Withdrawn
- 2006-03-31 ZA ZA200708641A patent/ZA200708641B/xx unknown
-
2007
- 2007-10-07 IL IL186426A patent/IL186426A0/en unknown
- 2007-10-10 NO NO20075153A patent/NO20075153L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1868597A1 (fr) | 2007-12-26 |
| BRPI0610663A2 (pt) | 2010-07-13 |
| IL186426A0 (en) | 2008-08-07 |
| KR20070121032A (ko) | 2007-12-26 |
| CN101171004A (zh) | 2008-04-30 |
| CA2604396A1 (fr) | 2006-10-12 |
| AU2006231117A1 (en) | 2006-10-12 |
| US20080255079A1 (en) | 2008-10-16 |
| GB0506835D0 (en) | 2005-05-11 |
| ZA200708641B (en) | 2009-08-26 |
| JP2008534663A (ja) | 2008-08-28 |
| WO2006106308A1 (fr) | 2006-10-12 |
| MX2007012300A (es) | 2007-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20075153L (no) | Terapeutisk anvendelse av nefopam og analoger derav | |
| NO20083036L (no) | Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av depresjon | |
| NO20074943L (no) | Roflumilast for behandlingen av diabetes mellitus | |
| NO20073816L (no) | Kombinasjonsterapi for behandling av diabetes og tilstander relatert dertil og for behandling av tilstanden som er bedret ved a oke blod GLP-1 nivaet | |
| NO20080084L (no) | Molekyler som er i stand til a hemme bindingen mellom NGF og TrkA-reseptoren som analgetika med forlenget effekt | |
| NO20082790L (no) | Behandling av type 2 diabetes med en kombinasjon av DPIV inhibitor og metformin eller thiazolidindion | |
| NO20065260L (no) | Tri(cyklo)substituerte amidforbindelser | |
| EA201101189A1 (ru) | Ингибитор sglt-2, предназначенный для лечения сахарного диабета типа 1, сахарного диабета типа 2, нарушенной толерантности к глюкозе или гипергликемии | |
| NO20082090L (no) | Pyridopyrimidinoninhibitorer av P13K alfa | |
| EA201200793A1 (ru) | Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин | |
| EA200801897A1 (ru) | Ингибиторы mnk2 на основе 8-гетероарилпурина для лечения метаболических нарушений | |
| NO20091700L (no) | Florizinanaloger som inhibitorer av glukose-ko-transporter 2 | |
| EA200870019A1 (ru) | Лактамовые соединения и способы их применения | |
| CL2012003026A1 (es) | Composicion farmaceutica que comprende pioglitazona y linagliptina; procedimiento de preparacion; uso en el tratamiento de la diabetes tipo 2 o la obesidad. | |
| EA201100302A1 (ru) | Лечение диабета у пациентов, для которых лечение метформином является неприемлемым | |
| NO20080010L (no) | GPCR-agonister | |
| MY145340A (en) | Milnacipran for the long-term treatment of fibromyalgia syndrome | |
| BRPI0722054A2 (pt) | Composição, kit, e métodos para diminuir um efeito colateral de tratamento com um inibidor da calcineurina, para aumentar um efeito terapêutico de um inibidor da calcineurina e para mudar a concentração de tacrolimus ou um análogo de tacrolimus em um compartimento fisiológico. | |
| IL192101A0 (en) | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels | |
| EA201490378A1 (ru) | ЛЕЧЕНИЕ РАССЕЯННОГО СКЛЕРОЗА С ИСПОЛЬЗОВАНИЕМ КОМБИНАЦИИ ЛАХИНИМОДА И ИНТЕРФЕРОНА-β | |
| NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
| ECSP077340A (es) | Nuevos derivados de pirimidina y su uso como moduladores del ppar-alfa | |
| ATE534652T1 (de) | Phosphono-pent-2-en-1-yl-nukleoside und analoga | |
| EA201170672A1 (ru) | Соединения, пригодные для лечения целлюлита | |
| GT200600409A (es) | Uso de agomelatina para obtener medicamentos propuestos para el tratamiento de trastornos del sueño en el paciente deprimido. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |